Prognostic Significance of Nonobstructive Left Main Coronary Artery Disease in Patients With and Without Diabetes: Long-Term Outcomes From the CONFIRM Registry.


Journal

Heart, lung & circulation
ISSN: 1444-2892
Titre abrégé: Heart Lung Circ
Pays: Australia
ID NLM: 100963739

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 14 05 2022
revised: 21 08 2022
accepted: 09 09 2022
pubmed: 7 11 2022
medline: 7 3 2023
entrez: 6 11 2022
Statut: ppublish

Résumé

Prognostic significance of non-obstructive left main (LM) disease was recently reported. However, the influence of diabetes mellitus (DM) on event rates in patients with and without non-obstructive LM disease is not well-known. We evaluated 27,252 patients undergoing coronary computed tomographic angiography from the COroNary CT Angiography Evaluation For Clinical Outcomes: An InteRnational Multicenter (CONFIRM) Registry. Cumulative long-term incidence of all-cause mortality (ACM) was assessed between DM and non-DM patients by normal or non-obstructive LM disease (1-49% stenosis). The mean age of the study population was 57.6±12.6 years. Of the 27,252 patients, 4,434 (16%) patients had DM. A total of 899 (3%) deaths occurred during the follow-up of 3.6±1.9. years. Compared to patients with normal LM, those with non-obstructive LM had more pronounced overall coronary atherosclerosis and more cardiovascular risk factors. After clinical risk factors, segment involvement score, and stenosis severity adjustment, compared to patients without DM and normal LM, patients with DM were associated with increased ACM regardless of normal (HR 1.48, 95% CI 1.22-1.78, p<0.001) or non-obstructive LM (HR 1.46, 95% CI 1.04-2.04, p=0.029), while nonobstructive LM disease was not associated with increased ACM in patients without DM (HR 0.85, 95% CI 0.67-1.07, p=0.165) and there was no significant interaction between DM and LM status (HR 1.03, 95% CI 0.69-1.54, p=0.879). From the CONFIRM registry, we demonstrated that DM was associated with increased ACM. However, the presence of non-obstructive LM was not an independent risk marker of ACM, and there was no significant interaction between DM and non-obstructive LM disease for ACM.

Sections du résumé

BACKGROUND BACKGROUND
Prognostic significance of non-obstructive left main (LM) disease was recently reported. However, the influence of diabetes mellitus (DM) on event rates in patients with and without non-obstructive LM disease is not well-known.
METHODS METHODS
We evaluated 27,252 patients undergoing coronary computed tomographic angiography from the COroNary CT Angiography Evaluation For Clinical Outcomes: An InteRnational Multicenter (CONFIRM) Registry. Cumulative long-term incidence of all-cause mortality (ACM) was assessed between DM and non-DM patients by normal or non-obstructive LM disease (1-49% stenosis).
RESULTS RESULTS
The mean age of the study population was 57.6±12.6 years. Of the 27,252 patients, 4,434 (16%) patients had DM. A total of 899 (3%) deaths occurred during the follow-up of 3.6±1.9. years. Compared to patients with normal LM, those with non-obstructive LM had more pronounced overall coronary atherosclerosis and more cardiovascular risk factors. After clinical risk factors, segment involvement score, and stenosis severity adjustment, compared to patients without DM and normal LM, patients with DM were associated with increased ACM regardless of normal (HR 1.48, 95% CI 1.22-1.78, p<0.001) or non-obstructive LM (HR 1.46, 95% CI 1.04-2.04, p=0.029), while nonobstructive LM disease was not associated with increased ACM in patients without DM (HR 0.85, 95% CI 0.67-1.07, p=0.165) and there was no significant interaction between DM and LM status (HR 1.03, 95% CI 0.69-1.54, p=0.879).
CONCLUSION CONCLUSIONS
From the CONFIRM registry, we demonstrated that DM was associated with increased ACM. However, the presence of non-obstructive LM was not an independent risk marker of ACM, and there was no significant interaction between DM and non-obstructive LM disease for ACM.

Identifiants

pubmed: 36336615
pii: S1443-9506(22)01126-X
doi: 10.1016/j.hlc.2022.09.014
pii:
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

175-183

Informations de copyright

Copyright © 2022 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Auteurs

Juhwan Lee (J)

Department of Medicine, Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA, USA; Department of Medicine, CHA University GUMI CHA Hospital, Gyeongsangbuk-do, South Korea.

Kashif Shaikh (K)

Department of Medicine, Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA, USA; Department of Medicine, University of Tennessee, Knoxville, Tennessee, USA.

Rine Nakanishi (R)

Department of Medicine, Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA, USA; Department of Cardiovascular Medicine, Toho University Graduate School of Medicine, Tokyo, Japan.

Heidi Gransar (H)

Department of Imaging and Medicine, Cedars Sinai Medical Center, Los Angeles, CA, USA.

Stephan Achenbach (S)

Department of Cardiology, Friedrich-Alexander-University Erlangen-Nuremburg, Erlangen, Germany.

Mouaz H Al-Mallah (MH)

Houston Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, TX, USA.

Daniele Andreini (D)

Centro Cardiologico Monzino, IRCCS Milan, Milan, Italy.

Jeroen J Bax (JJ)

Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.

Daniel S Berman (DS)

Department of Imaging and Medicine, Cedars Sinai Medical Center, Los Angeles, CA, USA.

Filippo Cademartiri (F)

Department of Radiology, Fondazione Monasterio/CNR, Pisa/Massa, Italy.

Tracy Q Callister (TQ)

Tennessee Heart and Vascular Institute, Hendersonville, TN, USA.

Hyuk-Jae Chang (HJ)

Division of Cardiology, Severance Cardiovascular Hospital and Severance Biomedical Science Institute, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea.

Kavitha Chinnaiyan (K)

Department of Cardiology, William Beaumont Hospital, Royal Oak, MI, USA.

Benjamin J W Chow (BJW)

Department of Medicine and Radiology, University of Ottawa, Ottawa, ON, Canada.

Ricardo C Cury (RC)

Department of Radiology, Miami Cardiac and Vascular Institute, Miami, FL, USA.

Augustin DeLago (A)

Capitol Cardiology Associates, Albany, NY, USA.

Gudrun Feuchtner (G)

Department of Radiology, Medical University of Innsbruck, Innsbruck, Austria.

Martin Hadamitzky (M)

Department of Radiology and Nuclear Medicine, German Heart Center Munich, Munich, Germany.

Joerg Hausleiter (J)

Medizinische Klinik I der Ludwig-Maximilians-Universität München, Munich, Germany.

Philipp A Kaufmann (PA)

Department of Nuclear Medicine, University Hospital, Zurich, Zurich, Switzerland.

Yong-Jin Kim (YJ)

Seoul National University Hospital, Seoul, South Korea.

Jonathon A Leipsic (JA)

Department of Medicine and Radiology, University of British Columbia, Vancouver, BC, Canada.

Erica Maffei (E)

Department of Radiology, Fondazione Monasterio/CNR, Pisa/Massa, Italy.

Hugo Marques (H)

UNICA, Unit of Cardiovascular Imaging, Hospital da Luz, Lisboa, Portugal.

Pedro de Araújo Gonçalves (P)

UNICA, Unit of Cardiovascular Imaging, Hospital da Luz, Lisboa, Portugal.

Gianluca Pontone (G)

Centro Cardiologico Monzino, IRCCS Milan, Italy.

Ronen Rubinshtein (R)

Department of Cardiology at the Lady Davis Carmel Medical Center, The Ruth and Bruce Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Todd C Villines (TC)

Division of Cardiovascular Medicine, Department of Medicine, University of Virginia Health System, Charlottesville, VA, USA.

Yao Lu (Y)

Department of Healthcare Policy and Research, New York-Presbyterian Hospital and the Weill Cornell Medical College, New York, NY, USA.

Jessica M Peña (JM)

Dalio Institute of Cardiovascular Imaging, Weill Cornell Medicine and NewYork-Presbyterian, New York, NY, USA.

Fay Y Lin (FY)

Dalio Institute of Cardiovascular Imaging, Weill Cornell Medicine and NewYork-Presbyterian, New York, NY, USA.

James K Min (JK)

Cleerly Inc, New York, NY, USA.

Leslee J Shaw (LJ)

Dalio Institute of Cardiovascular Imaging, Weill Cornell Medicine and NewYork-Presbyterian, New York, NY, USA.

Matthew J Budoff (MJ)

Department of Medicine, Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA, USA. Electronic address: mbudoff@lundquist.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH